Page last updated: 2024-12-06

5-methoxyindole-2-carboxylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-Methoxyindole-2-carboxylic acid is a naturally occurring indole derivative found in various plants. It exhibits a range of biological activities, including anti-inflammatory, antioxidant, and neuroprotective properties. It is of interest for its potential therapeutic applications in conditions like Alzheimer's disease and cancer. Research focuses on its synthesis, structural modifications, and biological activity evaluations. The compound's unique structure and potential for therapeutic development make it a subject of ongoing scientific study.'

5-methoxyindole-2-carboxylic acid: inhibitor of gluconeogenesis; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

5-methoxyindole-2-carboxylic acid : An indolecarboxylic acid that is indole-2-carboxylic acid carrying an additional methoxy substituent at position 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID20401
CHEMBL ID23961
CHEBI ID133222
SCHEMBL ID335235
MeSH IDM0052228

Synonyms (52)

Synonym
AC-19422
CBDIVE_015623
BB 0254592
5-methoxyindole-2-carboxylic acid
nsc-30927
nsc30927
indole-2-carboxylic acid, 5-methoxy-
4382-54-1
1h-indole-2-carboxylic acid, 5-methoxy-
5-methoxy-2-indolecarboxylic acid
acide methoxy-5 indole carboxylique-2 [french]
einecs 224-487-6
nsc 30927
5-methoxy-1h-indole-2-carboxylic acid
OPREA1_206851
5-methoxyindole-2-carboxylic acid, 97%
M-3500
STK386884
CHEBI:133222
5-methoxy-2-indolic acid
CHEMBL23961
AKOS000265769
HMS1613F05
M1271
A7010
A1809
5-methoxy-1h-indole-3-carboxylicacid
BBL010666
CCG-112235
unii-afk8l54ha2
acide methoxy-5 indole carboxylique-2
afk8l54ha2 ,
5-methoxyindol-2-carboxylic acid
FT-0620570
SCHEMBL335235
5-(methyloxy)-1h-indole-2-carboxylic acid
5-methoxy-1-h-indole-2-carboxylic acid
5-methoxy-indole-2-carboxylic acid
5-methoxyindole-2-carboxilic acid
5-methoxylindole-2-carboxylic acid
5-methoxy-1h-indole-2-carboxylic acid #
mfcd00005614
DTXSID40195944
AC-9836
5-methoxyindole-2-carboxylicacid
CS-W010727
SY050143
AS-15059
AMY11977
SB14717
EN300-96643
Z1096153758

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The dichotomy of the outcomes suggest that more studies are needed to determine optimum duration and dosage for MICA to lead to substantial motor and cognitive improvements, along with LTP change and neuroprotection."( Effects of dietary 5-methoxyindole-2-carboxylic acid on brain functional recovery after ischemic stroke.
Chen, Z; Forster, MJ; Huang, R; Li, W; Sumien, N; Vann, PH; Wong, JM; Yan, LJ; Yang, S, 2020
)
0.89
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
hypoglycemic agentA drug which lowers the blood glucose level.
EC 1.8.1.4 (dihydrolipoyl dehydrogenase) inhibitorAn EC 1.8.1.* (oxidoreductase acting on sulfur group of donors, NAD+ or NADP+ as acceptor) inhibitor that interferes with the action of dihydrolipoyl dehydrogenase (EC 1.8.1.4).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
indolecarboxylic acid
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Genome polyprotein Kd4.00002.90002.90002.9000AID146231
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID142989Inhibition of strychnine-insensitive [3H]glycine binding to the N-methyl-D-aspartate glutamate receptor of synaptic plasma membranes(SPM) prepared from rat forebrain1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
Novel indole-2-carboxylates as ligands for the strychnine-insensitive N-methyl-D-aspartate-linked glycine receptor.
AID146231Dissociation constant for HCV NS3 protease substrate binding site2004Journal of medicinal chemistry, May-06, Volume: 47, Issue:10
Non-peptidic small-molecule inhibitors of the single-chain hepatitis C virus NS3 protease/NS4A cofactor complex discovered by structure-based NMR screening.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (17.65)18.7374
1990's4 (23.53)18.2507
2000's3 (17.65)29.6817
2010's6 (35.29)24.3611
2020's1 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.31 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.68 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]